Ribosome Research Centre Pvt. Ltd.Ribosome Research Centre Pvt. Ltd.Ribosome Research Centre Pvt. Ltd.Ribosome Research Centre Pvt. Ltd.
Ribosome Research Centre building entrance
← Back to Blog & Articles
In-Vitro Mammalian Chromosomal Aberration Test

In-Vitro Mammalian Chromosomal Aberration Test (ISO 10993-3 & ISO 10993-33) – Using Human Peripheral Blood Lymphocytes

Ribosome Research Centre provides In-Vitro Mammalian Chromosomal Aberration Test as per ISO 10993-3 & ISO 10993-33 using Human Peripheral Blood Lymphocytes. This sensitive mammalian cell-based assay detects chromosome damage, identifies genetic risks early, and meets global regulatory requirements for medical devices, implantable devices, and raw materials.

Ribosome Research Centre Pvt. Ltd.

Share on LinkedIn
In-Vitro Mammalian Chromosomal Aberration Test (ISO 10993-3 & ISO 10993-33) – Using Human Peripheral Blood Lymphocytes

Genetic safety is a critical requirement for medical devices that come in contact with the human body. The In-Vitro Mammalian Chromosomal Aberration Test is a key genotoxicity test that evaluates whether a medical device, material, or extract can cause damage to chromosomes.

At Ribosome Research Centre Pvt. Ltd. (RRC), a Leading Global Contract Research Organization, we perform this test as per ISO 10993-3 & ISO 10993-33 using Human Peripheral Blood Lymphocytes in our ISO/IEC 17025 Compliant Lab.

Accurate • Reliable • Regulatory Ready

Why This Test is Critical

  • Detects Chromosome Damage

  • Sensitive Mammalian Cell-Based Assay

  • Meets Regulatory Requirements

  • Identifies Genetic Risks Early

This test helps manufacturers identify clastogenic potential before the product reaches clinical use, reducing regulatory risk and ensuring patient safety.

Our Testing Scope

Our chromosomal aberration testing supports a wide range of medical devices and materials:

1. Implantable Devices

Examples: Orthopedic, Cardio, Sutures

2. Surgical & Wound Care

Examples: Dressings, Gloves, Wound Care

3. Diagnostic Devices

Examples: Catheters, Tubing, Blood Devices

4. Ophthalmic & ENT

Examples: Contact Lenses, Nasal Devices

5. Raw Materials

Examples: Polymers, Adhesives, Textiles

Gold Standard Methodology

At Ribosome Research Centre, we follow a validated, gold-standard methodology:

  • Short-term ± S9

  • Continuous –S9

  • Mitotic Index

  • Cytotoxicity Evaluation

  • Validated Controls

This approach ensures scientific accuracy, reproducibility, and regulatory acceptance.

Results Interpretation

Non-Clastogenic:
No significant chromosomal damage. The test article does not show a significant increase in aberrations.

Clastogenic:
Significant increase in aberrations. The test article shows potential to cause chromosomal damage.

Our detailed report provides clear interpretation, raw data review, and regulatory-ready documentation to support your submission.

Why Choose Ribosome Research Centre?

  • ISO/IEC 17025 Compliant Lab

  • Experienced Genotoxicity & Biocompatibility Experts

  • Compliance with ISO 10993-3 & ISO 10993-33

  • Validated Controls and Gold Standard Methodology

  • Comprehensive Technical Documentation

  • Timely Project Execution

  • Audit and Inspection Support

We focus on delivering reliable, scientifically supported testing solutions that strengthen your biocompatibility program and help maintain product safety and regulatory compliance.

Contact Ribosome Research Centre

Looking for reliable In-Vitro Mammalian Chromosomal Aberration Test services?

Connect with Ribosome Research Centre to strengthen your biocompatibility and genotoxicity testing program.

Contact Numbers: +91 99041 55567 | +91 72111 55605

Email: ceo@ribosomeresearch.com | bd3@ribosomeresearch.com

Ribosome Research Centre Pvt. Ltd. (RRC) - Leading Global Contract Research Organization

Stay connected with science

Stay Informed. Stay Ahead in Research.

Subscribe to receive the latest updates on pharmaceutical research, clinical and pre-clinical testing, medical device safety, regulatory developments, scientific insights and industry events from Ribosome Research Centre.